GATTI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 3.054
AS - Asia 1.119
EU - Europa 728
SA - Sud America 253
AF - Africa 43
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.200
Nazione #
US - Stati Uniti d'America 3.016
SG - Singapore 457
CN - Cina 295
BR - Brasile 217
SE - Svezia 192
HK - Hong Kong 136
RU - Federazione Russa 109
DE - Germania 74
FI - Finlandia 66
IT - Italia 58
GB - Regno Unito 57
VN - Vietnam 57
FR - Francia 54
UA - Ucraina 46
IN - India 43
BD - Bangladesh 25
BE - Belgio 20
TR - Turchia 18
IQ - Iraq 15
CA - Canada 14
MX - Messico 14
AR - Argentina 13
ZA - Sudafrica 13
CI - Costa d'Avorio 11
JP - Giappone 11
ID - Indonesia 8
MA - Marocco 8
PK - Pakistan 7
PL - Polonia 7
SA - Arabia Saudita 7
CO - Colombia 6
CZ - Repubblica Ceca 6
UZ - Uzbekistan 6
ES - Italia 5
LT - Lituania 5
MY - Malesia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
EC - Ecuador 4
IE - Irlanda 4
JO - Giordania 4
PY - Paraguay 4
AT - Austria 3
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
GE - Georgia 3
NL - Olanda 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
AU - Australia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
LB - Libano 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UG - Uganda 1
VE - Venezuela 1
Totale 5.200
Città #
Fairfield 374
Ashburn 369
Chandler 311
Singapore 254
Woodbridge 214
Seattle 177
Nyköping 157
Houston 151
San Jose 136
Hong Kong 134
Cambridge 120
Ann Arbor 119
Wilmington 105
Jacksonville 103
Beijing 92
New York 72
Nanjing 51
Lawrence 40
Roxbury 40
Helsinki 36
Lauterbourg 36
Dallas 34
Los Angeles 32
Des Moines 29
Munich 26
Inglewood 23
Ho Chi Minh City 22
Boardman 21
San Diego 21
Brooklyn 20
Brussels 20
Princeton 17
São Paulo 17
Santa Clara 14
Columbus 13
Dearborn 13
The Dalles 12
Tianjin 12
Abidjan 11
Hanoi 11
Tokyo 11
Johannesburg 10
Bari 9
Denver 9
Pune 9
Shenyang 9
Belo Horizonte 8
Changsha 8
Hebei 8
London 8
Paris 8
Rome 8
Shanghai 8
Curitiba 7
Moscow 7
Nanchang 7
Orem 7
Zhengzhou 7
Ankara 6
Boston 6
Dhaka 6
San Francisco 6
Warsaw 6
Washington 6
Buffalo 5
Chicago 5
Council Bluffs 5
Dong Ket 5
Frankfurt am Main 5
Grafing 5
Guarulhos 5
Hefei 5
Mumbai 5
Rio de Janeiro 5
Tashkent 5
Turku 5
Amman 4
Atlanta 4
Brasília 4
Chennai 4
Delhi 4
Dublin 4
Erbil 4
Fortaleza 4
Haiphong 4
Jiaxing 4
Jinan 4
Milan 4
Montreal 4
New Delhi 4
Nuremberg 4
Porto Alegre 4
Redwood City 4
Aci Castello 3
Baghdad 3
Baku 3
Brno 3
Contagem 3
Goiânia 3
Guangzhou 3
Totale 3.792
Nome #
Hepatitis C virus clearance after direct-acting antivirals in cirrhotic patients by stages of liver impairment: the ITAL-C network study 211
F-18 FDG PET/CT in the diagnosis of a rare case of neurosarcoidosis in a patient with diabetes insipidus 210
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 196
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C 190
Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: Analysis of complications in a single centre over 20 years 155
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome 154
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 152
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 151
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin 149
Ablative therapies for intrahepatic cholangiocarcinoma 149
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage 149
Recent patents relating to HCV molecules like putative targets for therapeutic intervention. 148
Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance 143
B-cell depletion in the treatment of mixed cryoglobulinemia. 142
Optimization of direct anti-viral agent treatment schedule: Focus on HCV genotype 3 141
Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance 140
Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study 140
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 140
Caratterizzazione di lesione metastatica da carcinoma della mammella con angioecografia. Caso clinico 133
Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report. 131
Hepatitis C virus infection, lymphoproliferation and non-Hodgkin’s B cell lymphoma 130
High- Powered Microwaves Ablation: An Emerging and Safe Tool for Treatment of Intrahepatic Cholangiocarcinoma 126
Hepatitis C virus infection, mixed crioglobulinemia, and non-Hodgkin’s lymphoma: an emerging picture 120
Bone metastases in hepatocellular carcinoma: an emerging issue 113
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 112
18F-FDG PET/CT evaluation in diagnosis and follow-up of patients with hepato-cellular carcinoma 109
Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia 104
Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial 104
Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy 104
Hepatitis C virus infection involves CD34+ hematopoietic porgenitor cells in hepatitis C virus chronic carriers. 99
Alcolizzazione percutanea del piccolo HCC. Casistica personale 94
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 92
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 90
A Giant Gastric Hyperplastic Polyp in Non-Familial Juvenile Polyposis of the Stomach: A Case Report 86
Ruolo dell’ecotomografia tiroidea nel follow-up di pazienti affette da carcinoma mammario in trattamento chemioterapico adiuvante con antracicline 79
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study 75
Virus C dell’epatite, crioglobulinemia mista e linfomi non-Hodgkin 68
18F-FDG PET/CT evaluation in diagnosis and follow up of patients with hepato-cellular carcinoma 68
Trattamento con interferone pegilato-α2b in monoterapia o in associazione con ribavirina e amantadina in pazienti affetti da epatite cronica attiva HCV-correlata non responsivi a interferone non-pegilato 65
null 61
null 60
Trattamento antivirale in pazienti affetti da epatite cronica attiva HCV correlata e transaminasi normali 59
Termoablazione percutanea a radiofrequenza di epatocarcinoma 54
Termoablazione a radiofrequenza vs alcolizzazione percutanea nel trattamento del piccolo epatocarcinoma. Studio prospettico, randomizzato 48
null 47
Totale 5.291
Categoria #
all - tutte 21.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 68 20 29
2021/2022347 26 24 11 22 13 37 11 16 19 26 55 87
2022/2023698 82 96 76 72 68 90 4 82 85 4 23 16
2023/2024306 13 39 13 11 32 95 11 55 0 8 3 26
2024/2025800 21 19 62 32 41 76 108 79 30 43 91 198
2025/20261.339 272 70 82 129 190 104 191 42 147 112 0 0
Totale 5.291